Feasibility of Autologous Stem Cell Transplantation in Chronic Carriers of Hepatitis B and Hepatitis C Virus

References

• Lau J. Y.N., Lai L. C., Lin H. J., Lok A. S.F., Liang R. H.S., Wu P. C., Chan T. K., Todd D. Fatal reactivation of chronic hepatitis B virus infection following withdrawal of chemotherapy in lymphoma patients. Q J Med 1989; 36: 47–54
   Google Scholar
• Locasciulli A., Bacigalupo A., Van Lint M. T., et al. Hepatitis B virus (HBV) infection and liver disease after allogeneic bone marrow transplantation: a report of 30 cases. Bone Marrow Transplant 1990; 6: 25–29
   PubMed Web of Science ®Google Scholar
• Reed E. C., Myerson D., Corey L., Meyers J. D. Allogeneic marrow transplantation in patients positive for hepatitis B surface antigen. Blood 1991; 11: 195–200
   Google Scholar
• Thung S. N., Gerber M A, Klion F., et al. Massive hepatic necrosis after chemotherapy withdrawal in a hepatitis B virus carrier. Arch Intern Med 1985; 145: 1313–1314
   PubMed Web of Science ®Google Scholar
• Pariente E. A., Goudeau A., Dubois F., Degott C., Gluckman E., Devergie A., Brechot C., Schenmetzler C., Bernuau J. Fulminant hepatitis due to reactivation of chronic hepatitis B virus infection after allogeneic bone marrow transplantation. Dig Dis Sci 1988; 33: 1185–1191
   PubMed Web of Science ®Google Scholar
• Bird G. L.A., Smith H., Portmann B., Alexander G. J.M., Williams R. Acute liver decompensation on withdrawal of cytotoxic chemotherapy and immunosuppressive therapy in hepatitis B carriers. QJ Med 1989; 73: 895–902
   PubMedGoogle Scholar
• Cavanna L., Sballi G., Tanzi E., Romano L., Civardi G., Buscarini E., Vallisa D., Berte R., Rossi A. High prevalence of antibodies to hepatitis C virus in patients with lymphoproliferative disorders. Haematologica 1995; 89: 486–487
   Google Scholar
• Ferri C., Caracciolo F., Zignego A. L., La Civita L., Monti M., Longobardo G., Lombardini F., Greco F., Capochiani E., Mazzoni A., Mazzaro C., Pasero G. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol 1994; 88: 392–394
   PubMed Web of Science ®Google Scholar
• Bellentani S., Tiribelli C., Saccoccio G., et al. Prevalence of chronic liver disease in the general population of northen Italy: the Dionysos Study. Hepatology 1994; 20: 1442–1449
   PubMed Web of Science ®Google Scholar
• Silvestri F., Pipan C., Barillari G., Zaja F., Fanin F., Infanti L., Russo D., Falasca E., Botta A. G., Baccarani M. Prevalence of hepatitis C virus infection in patients with lymphproliferative disorders. Blood 1996; 10: 4296–4301
   Google Scholar
• Infanti L., Silvestri F., Fanin R., et al. The F-MACHOP regimen in the treatment of aggressive non-Hodgkin's lymphomas: a single centre experience in 72 patients. Heamatologica 1996; 81: 521–528
   PubMedGoogle Scholar
• Lau G. K.K., Liang R., Chiu E. K.W., Lee C. K., Lam S. K. Hepatic events after bone marrow transplantation in patients with hepatitis B infection: a case controlled study. Bone Marrow Transplant 1997; 19: 795–799
   PubMed Web of Science ®Google Scholar
• Silvestri F., Fanin R., Sperotto A., Geromin A., Cerno M., Infanti L., Stocchi R., Damiani D., Baccarani M. Lamivudine for the prevention of hepatitis B virus (HBV) reactivation during autologous stem cell (SC) transplantation: a case report. Blood 1998; 92: 338b, abstract
   Web of Science ®Google Scholar
• Galbraith R. M., Eddleston A. L.W.F., Williams R. Fulminant hepatic failure in leukaemia and chriocarcinoma related to withdrawal of cytotoxic drug therapy. Lancet 1975; 2: 528–530
   PubMed Web of Science ®Google Scholar
• Wands J. R. Subacute and chronic active hepatitis after withdrawal of chemotherapy (abstr). Lancet 1975; 2: 979
   PubMed Web of Science ®Google Scholar
• Hanson C. A., Sutherland D. E., Snover D. C., et al. Fulminant hepatic failure in an HBsAg carrier renal transplant patient following cessation of immunosuppressive therapy. Transplantation 1985; 39: 311–312
   PubMed Web of Science ®Google Scholar
• Scullard G. H., Smith C. I., Meringan T. C., Robinson W. S., Gregory P. B. Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B. Gastroenterology 1981; 81: 987–991
   PubMed Web of Science ®Google Scholar
• Hoofnagle J. H., Dusheiko G. M., Schafer D. F., et al. Reactivation of chronic hepatitis B virus infection by cancer chemotherapy. Ann Intern Med 1982; 96: 447–449
   PubMed Web of Science ®Google Scholar
• Rakela J., Redeker A. G., Weliky B. Effect of short-term prednisone therapy on amino transferase levels and hepatitis B virus markers in chronic type B hepatitis. Gastroenterology 1983; 84: 956–960
   PubMed Web of Science ®Google Scholar
• Brechot G., Pourcel C., Hadchouel M., et al. State of hepatitis B virus DNA in liver disease. Hepatologw 1982; 2: 279–345
   Google Scholar
• Lefkowitch J. H., Schiff E. R., Davis G. L., et al. Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. Gastroenterology 1993; 104: 595–603
   PubMed Web of Science ®Google Scholar
• Dienes H. P., Popper H., Arnold W., et al. Histology observations in human hepatitis non-A, non-B. Hepatology 1982; 2: 562–571
   PubMed Web of Science ®Google Scholar
• Mondelli M., Alberti A., Tremolada F., et al. In vitro cell-mediated cytotoxicity for autologous liver cell in chronic non-A, non-B hepatitis. Clin Exp Immunol 1986; 63: 147–155
   PubMed Web of Science ®Google Scholar
• Fong T. S., Valinluck B., Govindarajan S., Charboneau F., Adkins R. H., Redeker A. G. Short-term prednisone therapy affects aminotransferase activity and hepatitis C virus RNA levels in chronic hepatitis C. Gastroenterology 1994; 107: 196–199
   PubMed Web of Science ®Google Scholar
• Editorial. Chemotherapy and hepatitis B. Lancet 1989; 2: 1130–1137
   Google Scholar
• Villa E., Theodossi A., Portmann B., et al. Reactivation of hepatitis B virus infection in two patients: immunofluorescence studies of liver tissue. Gastroenterology 1981; 80: 1048–1050
   PubMed Web of Science ®Google Scholar
• Lok A. S.F., Liang R. H.S., Chiu E. K.W., Wong K. L., Chan T. K., Todd D. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Gastroenterology 1991; 100: 182–188
   PubMed Web of Science ®Google Scholar
• Davis G. L., Hoofnagle J. H. Reactivation of chronic hepatitis B virus infection. Gastroenterology 1991; 92: 2028–2030
   Google Scholar
• Dienstag J. L., Perrillo R. P., Schiff E. R., Bartholomew M., Vicary C., Rubin M. A preliminary trial of lami-vudine for chronic hepatitis B infection. New Engl J Med 1995; 333: 1657–1661
   PubMed Web of Science ®Google Scholar
• Schalm S. W., de Man R. A., Heijtink R. A., et al. New nucleoside analogues for chronic hepatitis B. J Hepatol 1995; 22: 52–56
   PubMed Web of Science ®Google Scholar
• Boker K. H.W., Ringe B., Kruger M., et al. Prostaglandin E plus famciclovir-a new concept for the treatment of severe hepatitis B after liver transplantation. Transplantation 1994; 57: 1706–1708
   PubMed Web of Science ®Google Scholar
• Tur-Kaspa R., Burk R. D., Shaul Y., et al. Hepatitis B virus DNA contains a glucocorticoid-responsive element. Proc Natl Acad Sci USA 1986; 83: 1627–1631
   PubMed Web of Science ®Google Scholar
• Chou C. K., Wang L. H., Lin H. M., et al. Glucocorticoid stimulates hepatitis B viral gene expression in cultured human hepatoma cells. Hepatology 1992; 16: 13–18
   PubMed Web of Science ®Google Scholar
• Ohtsu T., Sai T., Oka M., Sugai Y., Tobinai K. Activation of hepatitis B virus infection by chemotherapy containing glucocorticoid in hepatitis B virus carriers with haematological malignancies. Jpn J Clin Oncol 1991; 21: 360–365
   PubMed Web of Science ®Google Scholar
• Magrin S., Craxi A., Fabiano C., Simonetti G., Fiorentino G., Marino L., Diquattro O., DiMarco V., Liacono O., Volpes R., Almasio P., Urdea S. M., Neuwald P., Pescador S. R., Detmer J., Wilber J. C., Pagliaro L. Hepatitis C viremia in chronic liver disease: relationship to Interferon-alfa or corticosteroid treatment. Hepatology 1994; 19: 274–279
   Google Scholar
• Chen P. M., Fan S., Liu C. J., Hsieh R. K., Hwang J., Chuang W., Liu R. S.R., Hwa C. Changing of hepatitis B virus markers in patients treated with bone marrow transplantation. Transplantation 1995; 49: 708–713
   Web of Science ®Google Scholar